US Patent 11014965 Modulation of complement activity
Patent 11014965 was granted and assigned to Ra Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+152 characters)
Article
Patent abstract
The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110149650
Date of Patent
May 25, 2021
0Patent Application Number
167325020
Date Filed
January 2, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 1 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110149650
Date of Patent
May 25, 2021
0Patent Application Number
167325020
Date Filed
January 2, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+14 properties)
US Patent 11014965 Modulation of complement activity
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11014965
Date of patent
May 25, 2021
Patent application number
16732502
Date Filed
January 2, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11014965 Modulation of complement activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.